Medicine
Cavhanza 80 mg orally disintegrating tablet
Cavhanza 80 mg orally disintegrating tablet is a prescription medicine containing Nilotinib for oral use, marketed by Cycle Pharmaceuticals, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store and dispense to patient in original container only.
Key facts
- Active ingredient (INN)
- Nilotinib
- Brand
- Cavhanza
- Strength
- 80 mg
- Dosage form
- Orally disintegrating tablet
- Route
- Oral
- Packs
- 112 tablets
- Marketing authorisation holder
- Cycle Pharmaceuticals
- Manufacturer
- Cycle Pharmaceuticals
- Origin register
- US FDA, United States
- Storage
- Store and dispense to patient in original container only.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- L01EA03 Nilotinib
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 30 June 2026
- Identifiers
- RxCUI 2747509, 2747516, 2747518 +1DailyMed set ID 98b197ea-bca4-427e-8737-97f70a3262bcNDC 70709-192Application NDA217379
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 112 tablet, orally disintegrating in 1 bottle | 70709-192-12 | Cycle Pharmaceuticals | 30 June 2026 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Nilotinib
Clinical summary
Nilotinib is a kinase inhibitor indicated for the treatment of adult and pediatric patients greater than or equal to 1 year of age with newly diagnosed Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML) in chronic phase. MedsAcross supplies Nilotinib for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about NilotinibFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Tasigna prescribing information (Novartis Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
- Tasigna: European public assessment report (EPAR) · European Medicines Agency
- Nilotinib Accord: European public assessment report (EPAR) · European Medicines Agency
Need Cavhanza 80 mg orally disintegrating tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.